- Home
- REAL vs AVIR Comparison
REAL vs AVIR Comparison
Compare REAL & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REAL | AVIR |
|---|---|---|
| Founded | 2011 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 318.0M |
| IPO Year | 2019 | 2020 |
Fundamental Metrics
Financial Performance| Metric | REAL | AVIR |
|---|---|---|
| Price | $9.50 | $6.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 2 |
| Target Price | ★ $17.00 | $8.00 |
| AVG Volume (30 Days) | ★ 3.6M | 569.6K |
| Earning Date | 05-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 43.55 | 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $692,845,000.00 | $351,367,000.00 |
| Revenue This Year | $14.30 | N/A |
| Revenue Next Year | $10.19 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.38 | N/A |
| 52 Week Low | $4.61 | $2.46 |
| 52 Week High | $17.39 | $6.45 |
Technical Indicators
Market Signals| Indicator | REAL | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 27.64 | 77.84 |
| Support Level | $7.21 | $3.33 |
| Resistance Level | $11.48 | N/A |
| Average True Range (ATR) | 0.79 | 0.30 |
| MACD | -0.09 | 0.10 |
| Stochastic Oscillator | 0.11 | 80.68 |
Price Performance
Historical ComparisonAbout REAL The RealReal Inc.
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).